A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids.
- Published in:
- Human Reproduction Open, 2019, v. 2019, n. 4, p. N.PAG, doi. 10.1093/hropen/hoz027
- By:
- Publication type:
- Article